Physician

Cardiology

Dr. Michael A. Lauer, MD

Michael A. Lauer, MD is an expert in the field of Cardiology. He graduated from University of Cincinnati College of Medicine. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Michael Lauer is a published physician. He has 16 papers published. The most current publication "A randomized, controlled trial of saphenous vein graft intervention with a filter-based distal embolic protection device: TRAP trial."

Publications

Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry.
Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration.
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.
Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury.
Successful treatment of distal coronary guidewire-induced perforation with balloon catheter delivery of intracoronary thrombin.
Relation of matrix-metalloproteinase 3 found in coronary lesion samples retrieved by directional coronary atherectomy to intravascular ultrasound observations on coron...
Practice patterns and outcomes of percutaneous coronary interventions in the United States: 1995 to 1997.
Role of the "dogbone" effect of balloon-expandable stents: quantitative coronary analysis of DUET and NIR stent implantation introducing a novel indexing sys...
Assessing the appropriateness of coronary revascularization: the University of Maryland Revascularization Appropriateness Score (RAS) and its comparison to RAND expert...
Is atherosclerosis an infectious disease?
Overestimation of stent delivery balloon diameters by manufacturers' compliance tables: a quantitative coronary analysis of Duet and NIR stent implantation.
Cost analysis of bivalirudin in percutaneous coronary intervention.
Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndrome...
A randomized, controlled trial of saphenous vein graft intervention with a filter-based distal embolic protection device: TRAP trial.
Effect of anti-tumor necrosis factor-alpha polyclonal antibody on restenosis after balloon angioplasty in a rabbit atherosclerotic model.

Doctors Specialties

Cardiology
Interventional Cardiology

Accepted Insurances

Awards

CMS Meaningful Use Stage 1 Certification
Fellow (FACC)

Education

Cleveland Clinic Foundation
University of Maryland
University of Cincinnati College of Medicine

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Todd R. Adams, DO This Doctor is OpenDoctor Recommended.
	Dr. Steven T. Mast, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark A. Elliott, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Kevin J. Clayton, DO This Doctor is OpenDoctor Recommended.
	Dr. Roberto A. Corpus Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Dino Recchia, MD This Doctor is OpenDoctor Recommended.
	Dr. Thomas W. Crosby, MD This Doctor is OpenDoctor Recommended.
	Dr. Brian D. Jaffe, MD This Doctor is OpenDoctor Recommended.
	Dr. Anne M. Hepner, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael E. Schulte, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael J. Parker, MD This Doctor is OpenDoctor Recommended.
	M R. Nair, MB This Doctor is OpenDoctor Recommended.